miR‐200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to <scp>BRAF</scp> inhibitor treatmentShujing Liu, Xiaowei Xu, Tao Wang et al.|Pigment Cell & Melanoma Research|2015Cited by 53